Holdings of Euclidean Capital LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 9 in 1 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US ETF | 3,243,484 | 243.6M $ | |
| 2 | Vanguard Value ETF | 520,000 | 102M $ | |
| 3 | ISHARES TRUST | 369,600 | 17.3M $ | |
| 4 | ORIC Pharmaceuticals Inc | 989,410 | 12.5M $ | |
| 5 | Foghorn Therapeutics Inc | 1,573,761 | 7.5M $ | |
| 6 | PMV Pharmaceuticals Inc | 2,627,643 | 3.3M $ | |
| 7 | Alector Inc | 1,307,858 | 2.8M $ | |
| 8 | Surrozen Inc | 87,696 | 2.6M $ | |
| 9 | TENAYA THERAPEUTICS INC | 1,015,705 | 703.3K $ |
Sector breakdown
- Funds 4.4 %
- Unattributed 95.6 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 100.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 9 | 392.3M $ | 100.00 % |
Cite this page
Titelia. "Holdings of Euclidean Capital LLC". https://titelia.com/en/funds/US13F1825034